Santhera Pharmaceuticals Holding AG : Santhera Publishes Agenda for Annual
Santhera Pharmaceuticals Holding AG / Santhera Publishes Agenda for Annual
Shareholders' Meeting . Processed and transmitted by Thomson Reuters ONE. The
issuer is solely responsible for the content of this announcement.
Liestal, Switzerland, April18, 2013 - Santhera Pharmaceuticals (SIX: SANN)
announced today the agenda for the Annual Shareholder's Meeting at the
Company's premises in Liestal on May13, 2013.
The agenda items are:
1.Approval of the Annual Report, the Annual Financial Statements, the
Consolidated Financial Statements for 2012; Acknowledgment of the Reports
of the Auditors
2.Appropriation of the Results
3.Set-off of Capital Contribution Reserves and of Free Reserves with Loss
4.Discharge of the Members of the Board of Directors and of the Executive
Management from Liability for the Financial Year 2012
5.Elections of Members of the Board of Directors
6.Re-election of Auditors
7.Continuation of Business Operations or Liquidation/Opting-out/Other
Financial and Strategic Measures
The full invitation including detailed information on the agenda, motions and
explanations for shareholders is available on the Company's website
www.santhera.comunder Investors/Shareholders' Meeting.
* * *
For further information, contact
Thomas Meier, Chief Executive Officer
Phone: +41 61 906 89 64
Disclaimer / Forward-looking statements
This communication does not constitute an offer or invitation to subscribe for
or purchase any securities of Santhera Pharmaceuticals Holding AG. This
publication may contain certain forward-looking statements concerning the
Company and its business. Such statements involve certain risks, uncertainties
and other factors which could cause the actual results, financial condition,
performance or achievements of the Company to be materially different from
those expressed or implied by such statements. Readers should therefore not
place undue reliance on these statements, particularly not in connection with
any contract or investment decision. The Company disclaims any obligation to
update these forward-looking statements.
News release ASM
This announcement is distributed by Thomson Reuters on behalf of Thomson
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.
Source: Santhera Pharmaceuticals Holding AG via Thomson Reuters ONE
--- End of Message ---
Santhera Pharmaceuticals Holding AG
Hammerstrasse 49 Liestal Switzerland
Press spacebar to pause and continue. Press esc to stop.